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ABSTRACT
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Under the Supervision of Professor Dean T. Nardelli

Lyme disease, caused by Borrelia burgdorferi, is an increasingly important public
health concern, with tens of thousands of new cases being diagnosed each year, even in
previously non-endemic areas. It is known that symptoms of Lyme disease are caused
by an inflammatory immune response initiated to aid in clearance of the pathogen. Left
unchecked, these inflammatory responses can potentially increase tissue damage,
leading to increased disease severity. Mechanisms responsible for the control of the
inflammatory response to infection with B. burgdorferi are not entirely understood.
Evidence exists that regulatory T (Treg) cells, a population of Foxp3-expressing CD4+ T
cells known to play a vital role in controlling the immune response, may be important in
reducing disease associated with B. burgdorferi infection. However, the role of Treg cells
in host response to B. burgdorferi has not been examined fully. Here, we hypothesized
that Treg cells control the development and progression of Lyme disease following B.
burgdorferi infection. To test this hypothesis, two specific aims were addressed: (1)
determine the effect of Treg cells on the development of arthritis following infection with
B. burgdorferi; and (2) determine the effect of Treg cells on the control of the immune
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response following infection with B. burgdorferi. Using a mouse model that allows for
specific depletion of Treg cells, we demonstrate that depletion of Treg cells immediately
prior to infection with B. burgdorferi leads to significantly increased edema in the
tibiotarsal joints of mice infected with a low dose of organisms. We also provide evidence
that Treg cell depletion affects the ability of the immune system to prevent bacterial
dissemination. Depletion of Treg cells appeared not to have an effect on the development
of arthritis at the low doses of infection we used, despite the increased tibiotarsal joint
swelling. Several weeks after infection, increased levels of IL-10 were observed in the
serum of mice previously depleted of Treg cells. Collectively, these findings provide
partial support for the hypothesis. Treg cell depletion prior to infection could potentially
impact the induction of the initial immune response to B. burgdorferi, which could then
have subsequent downstream effects on the development of disease; however, further
studies are needed to test this hypothesis.
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CHAPTER 1: INTRODUCTION

I. Background
Lyme Borreliosis
Lyme borreliosis, more commonly known as Lyme disease, is the most common vectorborne infection in the United States, with approximately 30,000 new cases being
reported each year and an estimated 300,000 individuals predicted to acquire it per year
(Centers for Disease Control and Prevention 2019). In 2014, The CDC named Lyme
disease the fifth most common “Nationally Notifiable Disease” (Adams et al. 2016).
Initial symptoms of Lyme disease include general flu-like symptoms usually associated
with a characteristic “bull’s-eye” rash at the site of infection (Nau et al. 2009). As
infection progresses, the microorganisms spread to other organs, such as the heart,
brain, or joints (Nau et al. 2009). Although this disease is typically not considered to be
life threatening, it can significantly affect the quality of life of those infected, making this
disease an important public health concern.

The causative agent of Lyme disease in the United States is the spirochete Borrelia
burgdorferi (Steere et al. 2004). Discovered in 1982 by Wilhelm Burgdorfer (Burgdorfer
et al. 1982), this highly motile extracellular bacterium is not known to produce toxins but
possesses a variety of virulence factors which enable it to colonize hosts, migrate
through tissues by adhering to host cells, and evade the immune response (Steere et al.
2004). Of particular interest is the ability of this organism to adhere to a variety of host
tissue components using many different cell surface proteins. B. burgdorferi has been
shown to bind decorin (Guo et al. 1995), which is a proteoglycan found abundantly on
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collagen fibers in the skin and joints, using decorin-binding proteins A and B (DbpA and
DbpB). B. burgdorferi has also been shown to bind fibronectin (Probert and Johnson
1998), which is a major component of the extracellular matrix and is found in a variety of
tissues and organs, using the fibronectin-binding protein (BBK32). B. burgdorferi can
also establish infection by evading the immune response. This organism is able to bind
Factor H (Hellwage et al. 2001), which is responsible for regulating the alternative
complement pathway via C3b, a vital host complement component. The ability of the
organism to bind Factor H facilitates with its subsequent inactivation; thus, binding of
Factor H inhibits bacterial destruction by complement-mediated killing. These abilities
allow the organism to colonize the host and effectively establish infection.

Transmission of B. burgdorferi
B. burgdorferi is transmitted via the bite of the tick Ixodes scapularis (deer tick) or
Ixodes pacificus (black-legged tick). I. scapularis is the primary vector in the
Northeastern and upper Midwest regions of the United States, whereas I. pacificus is
the primary vector in the Western region of the United States (Stanek et al. 2011). In
areas where these ticks are endemic, Lyme disease is traditionally prevalent as well.
While many animals, including birds and rodents, can act as hosts for these ticks, the
white-tailed deer is one of the most common hosts as its large size allows for the
transport and support of many ticks at once (Stanek et al. 2011). Although the life cycle
of these ticks consists of four stages, the nymph stage is primarily responsible for
transmitting B. burgdorferi. Ticks must remain attached to the host for at least thirty-six
hours to transmit B. burgdorferi; therefore, the small size of the nymph provides an
advantage as it is less likely to be discovered and removed before transmission can
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occur (Hubalek 2009). Most human infection occurs between May and September,
when the nymph stage is particularly prevalent and humans are outdoors for extended
periods of time in endemic areas (Hubalek 2009).

B. burgdorferi is transmitted via the bite of infected ticks. Ticks themselves become
infected after ingesting blood from an infected animal. B. burgdorferi survives in the
midgut of the tick until it is transferred to a subsequent host when the infected tick
feeds. To facilitate its transmission to the mammalian host, B. burgdorferi alters the
expression of its outer surface proteins. Outer surface protein A (OspA) expression is
upregulated in the midgut of the tick (Schwan et al. 1995), demonstrating an important
role for OspA in attachment and colonization of the tick midgut (Pal et al. 2000). Upon
feeding, the expression of OspA is downregulated, which allows for the migration of B.
burgdorferi from the tick midgut to the salivary glands. This downregulation of OspA
expression correlates with an upregulation of OspC expression (Schwan and Piesman
2000), which is important for colonization of the mammalian host (Schwan et al. 1995)
and is required for infectivity (Grimm et al. 2003; Tilly et al. 2006). This shift in surface
protein expression is thought to be a result of changes in temperature, pH, and
osmolarity within the midgut of the tick as the tick ingests the blood during feeding
(Schwan and Piesman 2000).

Changing climate and animal host migration has been leading to the spread of diseasecarrying vectors to other parts of the country, with Lyme disease cases beginning to
appear outside of the previously endemic areas. Since the discovery of Lyme-diseaseassociated ticks in northwestern Wisconsin in the late 1960s, the infected ticks have
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been carried south and east, allowing for an increasing geographic distribution across
the state (Kugeler et al. 2015). Not only have the infected tick vectors spread across
the state of Wisconsin, they are also expanding in other regions of the country,
increasing the chances that humans will become exposed to this disease. Geographic
expansion studies have demonstrated that from 1993 to 2012, the incidence of Lyme
disease increased 320% in northeastern states and 250% in north central states
(Kugeler et al. 2015). No vaccines currently exist to prevent humans from developing
Lyme disease, making a more complete understanding of this disease relevant for
human health.

Clinical Manifestations, Diagnosis, and Treatment of Lyme Disease
Untreated Lyme disease affects multiple body systems and typically progresses through
three stages: early localized infection, early disseminated infection, and late persistent
infection (Strle and Stanek 2009). Early localized infection occurs within days to weeks
following the bite from an infected tick. Erythema migrans (EM), the characteristic
“bull’s-eye” rash that is a hallmark of Lyme disease, occurs in 70-80% of infected
patients (Steere et al. 2004). The center of the rash occurs at the site of the tick bite,
occasionally with intermittent areas of clearing and inflammation radiating out from the
center as the bacteria spread. In the absence of the rash, other symptoms of early
localized infection closely resemble the flu; thus, often leading to misdiagnosis. The
early disseminated stage occurs weeks to months following infection and is
characterized by the spread of B. burgdorferi to other organ systems. Clinical
manifestations at this stage of infection may include additional disseminated EM
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lesions, and musculoskeletal and neurological symptoms, as well as symptoms of
carditis (Strle and Stanek 2009). Musculoskeletal symptoms include myalgia or
arthralgia (Wright et al. 2012). One of the most common neurological symptoms of
Lyme disease is facial palsy, in which one half of the face exhibits a drooping
appearance indicative of paralysis caused by damage to the facial nerve (Hildenbrand
et al. 2009). Neurological symptoms such as lymphocytic meningitis, encephalitis,
numbness or tingling in the hands or feet, or nerve pain may also occur (Auwaerter et
al. 2004). B. burgdorferi can also invade heart tissue, causing symptoms of carditis.
Lyme carditis is characterized by atrioventricular block, which prevents the conduction
of electrical impulses through the heart leading to arrhythmias (Fish et al. 2008).
Additional symptoms of carditis include heart palpitations and the feelings of being lightheaded or dizzy (Scheffold et al. 2015). The late persistent stage occurs months to
years after infection and is generally characterized by the further spread of the bacteria
to the joint tissue, contributing to the development of arthritis (Steere et al. 2004). Also
present at this stage, although rare, are worsened neurological symptoms (Auwaerter et
al. 2004). Lyme arthritis is the most common late-stage symptom of Lyme disease and
primarily affects large joints such as the knee (Wright et al. 2012).

The presence of the EM rash is generally sufficient for diagnosing Lyme disease in
areas where the disease is endemic. However, there are incidences in which the rash
occurs in areas that are less visible or does not appear. Therefore, people may not
realize they have been infected and will not seek medical treatment early during the
course of infection. Lyme disease is diagnosed based on two-tiered serological testing.
This testing is beneficial in the absence of the EM lesion or when the visible lesion does

5

not resemble the typical “bull’s-eye” pattern (Wormser et al. 2006). The first tier is an
enzyme-linked immunosorbent assay (ELISA). If a positive ELISA test result is
obtained, then the second tier for confirmation is a Western blot for immunoglobulin M
(IgM) or immunoglobulin G (IgG) (Sanchez et al. 2016). As the antibody response to B.
burgdorferi develops slowly, diagnostic testing at the early stages of infection may yield
negative results (Depietropaolo et al. 2005). If infection with B. burgdorferi remains a
suspected cause, tests need to be repeated two to four weeks later (Depietropaolo et al.
2005). Testing for IgM or IgG is dependent on the length of time for which the
symptoms persisted; if symptoms have persisted for four weeks or longer, an IgG
immunoblot should be performed as the IgM antibody response begins to decline
(Steere et al. 2004). Early during infection, IgM immunoblots are more useful as these
antibodies are made first in response to infection (Wormser et al. 2006); however, as
infection progresses, the antibody response switches to IgG (Steere et al. 2004). Use
of IgM immunoblots for diagnosis in later stages of infection may yield false positive
results due to presence of cross-reactive antibodies (Steere et al. 2004), demonstrating
the need for more specific diagnostic tests.

Oral antibiotics, such as doxycycline or amoxicillin, are recommended for patients who
have been diagnosed with Lyme disease early during the course of infection (Wormser
et al. 2006). For those suffering from symptoms of disseminated infection, intravenous
administration of ceftriaxone is recommended (Wormser et al. 2006). If treated early
during infection, most patients suffer no lasting effects from disease. However, a lack of
diagnosis or misdiagnosis of symptoms, particularly those exhibited during the early
localized stage of infection, may lead to lack of treatment or administration of
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inadequate medications. Additionally, despite proper antibiotic treatment, a small
subset of individuals may continue to suffer from persistent symptoms.

Immunology of Lyme Arthritis
One of the common manifestations associated with the late-persistent stage of infection
is Lyme arthritis, which affects approximately 60% of infected individuals (Steere and
Glickstein 2004). Lyme arthritis is characterized by intermittent episodes of
inflammation in large joints, particularly the knee, followed by periods of remission.
Severe cases may result in cartilage and bone erosion, leading to permanent loss of
joint function (Steere et al. 2004). Upon infection with B. burgdorferi, the immune
system attempts to eliminate the bacteria, inducing a robust inflammatory response
which leads to clinical manifestations of disease. An unregulated inflammatory
response can lead to tissue damage consistent with the early disseminated and late
persistent stages of infection. Different subsets of adaptive immune cells have been
implicated in disease pathogenesis, particularly T helper type 1 (Th1) cells and T helper
type 17 (Th17) cells. A third subset of T helper cells, T helper type 2 (Th2) cells, has
been implicated in disease resolution.

Th1 cells are a type of immune cell responsible for the promotion of inflammation and
are believed to contribute to the development of arthritis following infection with B.
burgdorferi. Elevated numbers of Th1 cells have been found in the joint fluid of patients
with Lyme arthritis (Gross et al. 1998), suggesting a role for these cells in development
of disease. Murine studies have demonstrated that interferon-gamma (IFN-γ), a proinflammatory cytokine secreted by Th1 cells, contributes to disease pathogenesis (Kang
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et al. 1997). However, subsequent studies have demonstrated that Lyme arthritis can
be induced in the absence of IFN-γ (Brown and Reiner 1999), suggesting that additional
immune cells promote inflammation in Lyme arthritis.

Another pro-inflammatory cytokine, interleukin-17 (IL-17), is a possible additional
mediator of Lyme arthritis. Studies in a mouse model of severe Lyme arthritis
demonstrated that administration of anti-IL-17 antibodies prevented the development of
disease (Burchill et al. 2003). This finding implicated IL-17 as another contributor to the
development of Lyme arthritis. IL-17 is the primary cytokine produced by Th17 cells,
suggesting Th17 cells may also be involved in arthritis development. Further support
for this conclusion was provided upon analysis of interleukin-23 (IL-23), a cytokine
crucial for the survival of Th17 cells. Blocking of IL-23 with anti-IL-23 antibodies
prevented the development of arthritis in mice and decreased the amount of IL-17
produced to contribute to arthritis development (Kotloski et al. 2008).

Studies of human patients have suggested that Th17 cells are also involved in the
development of Lyme arthritis. These cells can be induced by the B. burgdorferi
neutrophil-activating protein A (NapA). NapA-specific Th17 cells were found to
contribute to inflammation by secretion of IL-17, which led to bone destruction (Codolo
et al. 2008). Recently, it has been found that elevated levels of IL-23 were present in a
subset of individuals with an erythema migrans rash who suffered from arthritis following
antibiotic administration (Strle et al. 2014). This also suggests that Th17 responses
contribute to disease pathology.
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Conversely, the presence of Th2 cells is correlated with a faster resolution of Lyme
arthritis. Accumulation of Th2 cells in the joint fluid of patients with Lyme arthritis was
found to be correlated with the down-regulation of Th1 cells (Gross et al. 1998). This
increase in Th2 cell numbers led to a shorter duration and decreased severity of arthritis
(Gross et al. 1998). Higher numbers of Th2 cells may correlate with production of
increased levels of their characteristic cytokine, interleukin-4 (IL-4). Further support for
the role of Th2 cells in disease was provided by a study in BALB/c mice, which
demonstrated that high levels of IL-4 correlated with decreased arthritis severity
following infection with B. burgdorferi and that blocking of IL-4 resulted in more severe
arthritis (Matyniak and Reiner 1995). However, further studies demonstrated that IL-4
was not necessary for resistance to development of arthritis but may instead play a role
in the stimulation of an effective immune response against B. burgdorferi (Brown and
Reiner 1999).

Antibiotic-Refractory Lyme Arthritis
Antibiotic therapy is usually sufficient to resolve arthritis; however, symptoms persist in
10% of patients (Steere and Glickstein 2004). This persistence of arthritic symptoms
despite appropriate antimicrobial treatment is termed antibiotic-refractory Lyme arthritis.
Antibiotic-refractory Lyme arthritis is defined as persistent inflammation of the joint for at
least two months following completion of a course of antibiotics (Stanek et al. 2011).
The precise explanation for why this small subset of patients continues to suffer from
lasting effects of disease has not been elucidated; however, a variety of plausible
mechanisms have been proposed. Two such mechanisms include induction of an
autoimmune response or the persistence of spirochetal antigens within the joint tissue.
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Major histocompatibility complex class II human leukocyte antigen (HLA)-DR4-mediated
presentation of autoantigens is believed to contribute to the development of antibioticrefractory Lyme arthritis (Steere and Glickstein 2004). Recently, it was found that
endothelial cell growth factor (ECGF), a chemotactic factor that stimulates proliferation
of endothelial cells and also induces angiogenesis, was elevated in the joint fluid and
tissue of patients with antibiotic-refractory Lyme arthritis (Drouin et al. 2013). B and T
cell responses to ECGF were found to occur in these patients (Drouin et al. 2013),
suggesting an autoimmune mechanism in the development of antibiotic-refractory Lyme
arthritis.

Analysis of synovial fluid (Nocton et al. 1994) and synovial tissue samples (Carlson et
al. 1999) from patients with antibiotic-refractory Lyme arthritis by polymerase chain
reaction (PCR) for probes specific to B. burgdorferi outer surface proteins did not reveal
the presence of viable spirochetes. Thus, the persistent symptoms in these patients
were not believed to be due to chronic infection. A study in mice treated with
doxycycline demonstrated that B. burgdorferi antigens persisted in cartilage and joint
surfaces for extended periods of time following treatment (Bockenstedt et al. 2012).
This finding suggests that antibiotics eliminate infectious bacteria from the host, but
antigenic fragments may not be effectively cleared. In addition, Wormser et al.
proposed the “amber theory”, which suggests that dead B. burgdorferi spirochetes, and
their antigenic fragments, can be found in the connective tissue of infected patients
(Wormser et al. 2012). When alive, these microorganisms attach to, and colonize, joint
tissue, and may remain attached following their death after antimicrobial therapy.
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These confined microorganisms and their fragments may gradually be released into the
joint space over time, eliciting an inflammatory response (Wormser et al. 2012).
Peptidoglycan, a major component of the bacterial cell wall, has recently been identified
as a potential persistent antigen contributing to the pathogenesis of Lyme arthritis, with
peptidoglycan unique to B. burgdorferi being detected in 94% of synovial fluid samples
taken from numerous patients with antibiotic-refractory Lyme arthritis (Jutras et al.
2019). These dead spirochetes and antigenic fragments may still stimulate an immune
response but will not yield a positive PCR result.

Murine Models of Lyme Disease
Researchers utilize mouse models to investigate the pathogenesis of Lyme disease.
Some aspects of disease, particularly carditis and arthritis, resemble those seen in
humans following infection with B. burgdorferi. Studies of Lyme borreliosis in mice
revealed that spirochetes disseminate to the spleen and through the blood to distant
tissues such as the heart and joints within a few days after inoculation into the skin, and
subsequently induce inflammation in these tissues (Barthold et al. 1991). Disease
manifestations correlated with the appearance of spirochetes within these target
tissues, and it was determined that the immune responses to infection in mice were
characteristic of those seen in humans (Barthold et al. 1991). It has been established
that mouse strains of differing genetic backgrounds vary in their response to infection
with B. burgdorferi. For example, C3H mice have been shown to develop severe
arthritis following infection. BALB/c mice have been shown to develop carditis, and, in
the case of arthritis, a greater number of joints were involved than that seen in C3H
mice; however, disease severity is decreased in these mice (Barthold et al. 1990). By
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contrast, C57BL/6 mice tend to exhibit minimal or mild symptoms of carditis or arthritis
(Barthold et al. 1990). Additionally, the disease manifestations associated with varied
doses of B. burgdorferi differ among mouse strains. C57BL/6 mice are resistant to
arthritis development at a variety of doses of B. burgdorferi, ranging from 2x102 to 2x105
organisms (Ma et al. 1998). In contrast, BALB/c mice exhibit a dose-dependent
response to B. burgdorferi infection, as infection with higher doses of bacteria correlated
with greater arthritis severity, while infection with lower doses of bacteria correlated with
little to no arthritis (Ma et al. 1998).

Immunological differences may explain differences in clinical manifestations between
mouse strains. When compared to the highly Lyme disease-susceptible C3H mice,
BALB/c mice tend to be more resistant to disease. Early during infection, BALB/c mice
develop a Th1 response, as evidenced by elevated levels of IFN-γ and IL-2 (Zeidner et
al. 1997). Further studies demonstrated that both C3H and BALB/c mice produced
higher levels of IFN-γ early in Lyme arthritis (Kang et al. 1997), indicating that the initial
development of Lyme arthritis is mediated by a Th1 response. However, two weeks
after infection, an elevated level of IL-4 was observed only in BALB/c mice, and this
correlated with decreased arthritis severity in this strain (Kang et al. 1997). This
indicates that the decreased arthritis severity seen in BALB/c mice was likely mediated
by a Th2 response. As the BALB/c mice tend to be naturally biased towards developing
a Th2 response, this may explain the difference in disease severity between BALB/c
and C3H mice. Taken together, these findings suggest that the Th2 response in
BALB/c mice, although not protective, may contribute to a faster resolution of Lyme
arthritis than that seen in C3H mice. Differences in disease severity are also observed
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between BALB/c mice and C57BL/6 mice, with C57BL/6 mice being more resistant to
the development of arthritis, which could also be attributed to immunological differences
between these two mouse strains.

Regulatory T Cells
Regulatory T (Treg) cells are a population of T cells responsible for control of the
immune response. Treg cells have been implicated in preventing graft vs. host disease.
Additionally, immune dysregulation, possibly due to non-functional Treg cells, has been
linked to development of autoimmune diseases such as diabetes, thyroiditis,
inflammatory bowel diseases, and rheumatoid arthritis (Brusko et al. 2008). Treg cells
were previously characterized by their expression of CD4, and high levels of CD25, but
are now distinguished by their expression of Foxp3 (forkhead box P3). Foxp3 is a
transcription factor that is critical for the development of Treg cells. It is regarded as a
molecular marker unique to Treg cells (Fontenot et al. 2003), making this important for
distinguishing Treg cells from other populations of immune cells.

Differentiation of naïve T cells into Treg cells is stimulated by transforming growth factor
beta (TGF-β), which is a cytokine that has varying effects depending on the
environmental context (Sanjabi et al. 2009). TGF-β, in the presence interleukin 6 (IL-6),
leads to the production of Th17 cells, whereas TGF-β alone stimulates development of
Treg cells (Bettelli et al. 2006). Additionally, TGF-β signaling has been found to be
responsible for Foxp3 induction in the development of natural Treg cells, as deletion of
the TGF-β receptor blocked their development (Liu et al. 2008).
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The development of “depletion of regulatory T cell”, or DEREG, mice, has enabled
researchers to study the effects of Treg cells in various diseases. DEREG mice have
been engineered to express a fusion protein comprised of a diphtheria toxin (DTx)
receptor and an enhanced green fluorescent protein. This protein is under the control of
the foxp3 promoter (Lahl et al. 2007). As Foxp3 is regarded as the definitive marker for
identification of Treg cells (Fontenot et al. 2003), this mouse model allows for the
selective depletion of Treg cells via administration of small amounts of diphtheria toxin
(DTx). With two consecutive days of injection with 1 µg of DTx (Lahl and Sparwasser
2011), 95% to 98% of Foxp3+ Treg cells are depleted (Lahl et al. 2007).

Role of Regulatory T Cells in Lyme Disease
Studies in mice have implicated a role for CD4+CD25+ putative Treg cells in
experimental Lyme arthritis. In IFN-γ-deficient mice primed and infected with Borrelia
species, treatment with anti-IL-17 antibody prevented disease and resulted in an
increase in the numbers of CD4+CD25+ T cells (Nardelli et al. 2004). Administration of
anti-CD25 antibodies at the time of IL-17 neutralization decreased the numbers of
CD4+CD25+ T cells and caused these mice to develop severe arthritis (Nardelli et al.
2004). In addition, adoptive transfer of CD4+CD25+ T cells obtained from IFN-γdeficient mice treated with anti-IL-17 antibody prevented the development of arthritis
(Nardelli et al. 2005). However, in B. burgdorferi-infected IFN-γ-deficient mice in which
IL-17 was not blocked, administration of anti-CD25 antibody did not have a significant
effect on arthritis (Nardelli et al. 2006). This suggested a role for putative CD4+CD25+
Treg cells in the prevention of Lyme arthritis, and that their development was linked to
IL-17. This was supported by the findings of Bettelli et al., in which a cytokine-
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dependent, inverse relationship between the development of Th17 cells and Treg cells
was demonstrated. The “anti-inflammatory” environment found in the animals treated
with anti-IL-17 antibody likely led to the development of Treg cells, whereas the IL-17driven inflammation in the untreated animals did not lead to development of Treg cells.
Together, these findings provided initial support for the conclusion that symptoms of
Lyme disease may occur as a result of lower numbers of Treg cells.

Additionally, a role for Treg cells in the control of human Lyme arthritis has been
suggested. It was shown that higher numbers of Treg cells in the joint fluid of patients
with antibiotic-resistant Lyme arthritis correlate with a faster eventual resolution of
arthritis (Shen et al. 2010). In addition, it has been shown that patients with antibioticrefractory disease have lower numbers of Treg cells than patients who respond to
antibiotics (Vudattu et al. 2013). These findings support a possible role for Treg cells in
the control of arthritis development in patients with antibiotic-refractory Lyme arthritis.

More recent studies have demonstrated that specific depletion of Treg cells prior to
infection with B. burgdorferi caused the development of arthritis in DEREG mice of the
otherwise arthritis-resistant C57BL/6 mouse strain (Nardelli et al. unpublished data). In
addition, depletion of Treg cells after infection of these mice resulted in an increase in
swelling of the hind paws. These findings provide more direct support for a role for Treg
cells in the control of Lyme arthritis. However, while the results of these experiments
demonstrated a role for Treg cells in a model of resistance to Lyme disease, the role of
Treg cells has not been studied in the context of disease, as would occur in susceptible
mouse strains.
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II. Hypothesis and Specific Aims
Lyme disease is a multi-stage disease that affects multiple organ systems of the
body. Clinical manifestations of disease result from the inflammatory response elicited
to aid in clearance of the pathogen. Treg cells are a subset of cells responsible for
controlling the immune system (Sakaguchi et al. 2008). While previous studies have
demonstrated a possible role for Treg cells in controlling the development of Lyme
arthritis, the role of Treg cells has not been studied directly in the context of Lyme
disease to a great extent. Additionally, little evidence exists as to the role of Treg cells
in the control of the immune response to disseminated infection with B. burgdorferi. The
overall objective of this thesis is to determine the role of Treg cells in the development
and progression of Lyme disease in a disease-susceptible mouse model.
The central hypothesis of this thesis is that Treg cells control the development
and progression of Lyme disease following B. burgdorferi infection. To test this
hypothesis, two specific aims were addressed. The first specific aim was to determine
the effect of Treg cells on the development of arthritis following infection with B.
burgdorferi. The working hypothesis of this specific aim was that depletion of Treg cells
will exacerbate tibiotarsal joint swelling and arthritis following B. burgdorferi infection.
The second specific aim was to determine the effect of Treg cells on the control of the
immune response following infection with B. burgdorferi, with the working hypothesis
that depletion of Treg cells would result in an increased ability to control bacterial
dissemination and increased levels of pro-inflammatory cytokines following B.
burgdorferi infection.
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CHAPTER 2: MATERIALS AND METHODS

Mice: Preliminary experiments were conducted using four-week-old wild-type (WT)
BALB/c mice purchased from The Jackson Laboratory (Bar Harbor, ME). These WT
mice were allowed to acclimate to the new housing facility and were used for
experiments beginning at six weeks of age. All studies were completed using six-toeight-week-old WT mice and “depletion of regulatory T cell,” or DEREG, mice on the
BALB/c background. BALB/c DEREG mice were bred in-house. Mice were housed at
the University of Wisconsin-Milwaukee Animal Research Center in a humidity-controlled
environment at a temperature of 21°C with a regulated 12-hour light and dark cycle.
Food and acidified water were provided ad libitum. All protocols were reviewed and
approved by the University of Wisconsin-Milwaukee Institutional Animal Care and Use
Committee (IACUC).

Group Assignment: For preliminary experiments, WT BALB/c mice were randomly
assigned to groups which consisted of mice infected with either 2X103, 2X104, or 2X105
organisms (described below). Mice administered the vehicle, phosphate buffered saline
(PBS) supplemented with heat-inactivated normal mouse serum (NMS) comprised an
uninfected control group. For all subsequent studies (described below), both WT and
DEREG mice were randomly assigned to groups. Some groups of BALB/c WT and
BALB/c DEREG mice were administered diphtheria toxin (DTx) in PBS prior to infection
with B. burgdorferi. In addition, groups of BALB/c DEREG mice were administered PBS
alone prior to infection with B. burgdorferi. Additional groups consisted of BALB/c
DEREG mice administered DTx in PBS prior to injection with PBS supplemented with
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NMS and BALB/c DEREG mice administered PBS alone prior to injection with PBS
supplemented with NMS. All groups consisted of three to eight mice.

Genotyping: Genotyping of pups was performed according to protocols developed by
The Jackson Laboratory (Bar Harbor, ME) using a tail sample obtained at the time of
weaning. DNA was extracted from the tail samples by adding 75 µL of a digestion
buffer consisting of 25 mM NaOH and 0.2 mM EDTA, and boiling for one hour at 98°C.
Samples were then cooled to room temperature, and 75 µL of 40 mM Tris HCl pH of 5.5
was added to each sample. Samples were centrifuged at 4,000 rpm for three minutes
and then used for polymerase chain reaction (PCR) amplification. Forward and reverse
primer sequences used for characterization of WT mice were
5’-CAAATGTTGCTTGTCTGGTG-3’ and 5’-GTCAGTCGAGTGCACAGTTT-3’,
respectively (Eurofins Genomic, Louisville, KY). Forward and reverse primer
sequences for the transgene were 5’-CCCAGGTTACCATGGAGAGA-3’ and 5’GAACTTCAGGGTCAGCTTGC-3’, respectively (Eurofins Genomic, Louisville, KY). WT
and transgene primers were used in separate PCR reactions, which were prepared by
adding 12.0 µL of Denville Hot Start Mastermix, 0.8 µM of each forward and reverse
primers, 5.0 µL of PCR grade water, and 4.0 µL of DNA, for a 25 µL total reaction
volume. The PCR amplification protocol consisted of an initial denaturation step at
94°C for two minutes, followed by 35 cycles of denaturation at 94°C for 45 seconds,
annealing at 60°C for 30 seconds, and extension at 72°C for two minutes, followed by a
final extension step at 72°C for ten minutes, and a final hold step at 4°C. Amplified DNA
products were run on a 1.5% weight per volume (w/v) agarose gel containing ethidium
bromide at 135-140 volts for one hour and were imaged under ultraviolet light. DEREG
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mice were identified by the presence of the transgene, which was confirmed by the
appearance of a 380 base pair sized band on the gel.

Depletion of Treg Cells: Lyophilized diphtheria toxin (DTx) from Corynebacterium
diphtheriae (Calbiochem, San Diego, CA; Fisher Scientific, Lenexa, KS) was
reconstituted in filter-sterilized PBS, aliquoted, and then stored at -80°C until use.
Diphtheria toxin was diluted from stock solutions into filter-sterilized PBS to a final
concentration of 0.02 µg/mL. Fifty µL (1 µg) of DTx in PBS, or PBS alone, was injected
intraperitoneally into the mice for two consecutive days prior to infection with B.
burgdorferi (Day -2 and Day -1, respectively). Previous studies have demonstrated that
1 µg of DTx, administered on two consecutive days, was sufficient for depleting Treg
cells for approximately five days following administration (Lahl and Sparwasser 2011).
Mice were anesthetized prior to all injections with a 20% volume per volume (v/v)
mixture of isoflurane in propylene glycol. Weight loss is a common side effect following
administration of DTx (Mayer et al. 2014). To monitor for any potential morbidity
associated with DTx administration, mice were weighed immediately prior to
administration of DTx and then every day following injection until the mice began
exhibiting consistent weight gain, at which time mice were weighed every four days until
euthanasia.

Flow Cytometry: In a preliminary experiment, spleens were collected on the day
immediately following administration of a second dose of DTx in order to assess the
efficacy of DTx in depleting Treg cells. A single cell suspension of splenocytes was
prepared by teasing apart the spleens and passing the cells through a 0.2 µm sterile
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nylon mesh filter into cold Dulbecco Modified Eagle’s Medium (DMEM). Splenocytes
were then enumerated using a hemocytometer and placed into chilled flow tubes. The
eBioscience Mouse Regulatory T Cell Staining Kit (Thermo Fisher Scientific, Waltham,
MA) was used for flow cytometric analysis of Treg cells following the manufacturer’s
protocols. Cells were incubated with 1.5 µL of both fluorescein isothiocyanate (FITC)labeled anti-CD4 antibodies and phycoerythrin (PE)-labeled anti-CD25 antibodies.
Cells were fixed and permeabilized and then incubated with 1.5 µL of allophycocyanin
(APC)-labeled anti-Foxp3 antibodies. Compensation controls consisted of both singlestained and double-stained populations for all possible antibody combinations, with
isotype control antibodies being used as unstained controls. Data were acquired using
a BD FACSAria flow cytometer using FlowJo software (BD Biosciences, San Jose, CA).
Events were gated to include all lymphocytes, with ten thousand events being collected
and analyzed using a dot plot.

Bacterial Preparation and Infection: Borrelia burgdorferi strain B31-A3 organisms grown
in modified Barbour-Stoenner-Kelly (BSK) medium were generously provided by Dr.
Jenifer Coburn (Medical College of Wisconsin) and were frozen at -80°C until use. Low
passage (<10) organisms were grown by adding 10 µL of stock culture to 4 mL of BSK
medium with or without the presence of 2.5 µg/mL Amphotericin B, 20 µg/mL
Fosfomycin, and 50 µg/mL Rifampin (Curtis et al. 2018) and incubated at 34°C. Growth
and motility of B. burgdorferi were visualized using dark-field microscopy.

On the day of infection, microbes were washed twice in PBS supplemented with NMS.
Microbes were resuspended in PBS supplemented with NMS and were visualized by
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dark field microscopy for motility. Viable organisms were enumerated using a PetroffHausser counting chamber. Spirochetes were then diluted to different concentrations
depending upon the infectious dose to be used for experiments. Mice were
anesthetized with a 20% v/v mixture of isoflurane in propylene glycol and then injected
subcutaneously between the scapulae with 1X102, 1X103, 2X103, 2X104, or 2X105
organisms in 20 µL of PBS supplemented with NMS. Non-infected control groups
consisted of mice injected with PBS supplemented with NMS.

Assessment of Tibiotarsal Joint Swelling: Edematous changes in the tibiotarsal joints of
mice were assessed in order to provide a measure of inflammation associated with B.
burgdorferi infection. Mice were anesthetized with a 20% v/v mixture of isoflurane in
propylene glycol. A digital caliper (Marathon) was used to measure the width and
thickness of the tibiotarsal joint. The width and thickness measurements were then
averaged to provide a mean caliper reading. For preliminary experiments, baseline
measurements were obtained prior to infection (Day 0) and then tibiotarsal joints were
measured every seven days following infection for a total of 35 days. In one study,
baseline measurements were obtained the day following administration of diphtheria
toxin just prior to infection with B. burgdorferi, and joints were measured every four days
following infection for a period of 20 days. In another study, baseline measurements
were obtained, and joints were measured every four days following infection for a period
of 35 days. Changes in tibiotarsal joint swelling were determined by calculating the
difference from baseline measurements.

21

Pathological Assessment of Arthritis: Hind paws were amputated above the knee joint,
and one hind paw from each mouse was fixed in 10% buffered formalin. Blinded
histopathological analysis was performed by a board-certified pathologist (Dr. Michael
Lawlor, Medical College of Wisconsin). Pathology of the hind paws was scored on a
scale of 0-3 based on the degree of leukocytic infiltration, hyperplasia, and cartilage and
bone erosion. A score of 0 indicated absence of pathology; a score of 1 indicated a
single small focus of inflammation; a score of 2 indicated two or three small foci of
inflammation; and a score of 3 indicated several larger areas of inflammation.

Quantification of Bacterial Load in Mouse Tissue: The remaining hind paw and a
bisected portion of the hearts were flash frozen in liquid nitrogen and then stored at 80°C to be used for quantitative polymerase chain reaction (qPCR) analysis of bacterial
load in these tissues. DNA was extracted from these tissues using the Qiagen DNeasy
Mini Kit (Qiagen, Germantown, MD) following the manufacturer’s protocol. Extracted
DNA was quantified using a NanoDrop One (Thermo Scientific, Waltham, MA).
Bacterial load was assessed using a Synergy Brands, Inc. (SYBR) green-based qPCR
technique described by Ristow et al. (2012). Primers for the B. burgdorferi
chromosomal gene recA were used [(forward: 5-GCAGCTATCCCACCTTCTTT-3’);
(reverse: 5’-ATGAGGCTCTCGGCATTG-3’)]. Values were normalized based on copies
of Mus musculus β-actin [(forward: 5’-TCACCCACACTGTGCCCATCTACGA-3’);
(reverse: 5’-GGATGCCACAGGATTCCATACCCA-3’)]. Standard curves for bacterial
and mouse targets were obtained and used as the basis for quantification of bacterial
load within tissue samples. Separate reaction mixtures were prepared for each primer
set, with the reaction mixture consisting of 10 µL of PowerUp SYBR Green Master Mix

22

(Life Technologies, Carlsbad, CA), 0.5 µM of both forward and reverse primers for either
gene, 1 µL of PCR grade water, 2.5 mM MgCl2, and 5 µL of DNA. The amplification
protocol consisted of a pre-cycling step at 50°C for two minutes and an initial
denaturation step at 95°C for two minutes, followed by 40 cycles of denaturation at 95°C
for 15 seconds and annealing at 60°C for one minute. A melt curve analysis protocol
consisted of 15 seconds at 95°C, one minute at 60°C, then gradually heating to 95°C for
15 seconds. Analyses were performed using an Applied Biosystems StepOnePlusTM
Real-Time PCR System (Applied Biosystems, Waltham, MA). B. burgdorferi recA gene
copies were normalized to mouse β-actin after being calculated from standard curves.

Analysis of Serum Cytokines: Blood was collected at the time of euthanasia by
intracardiac puncture and sera were obtained and stored at -80°C until use. A Mouse
Magnetic Luminex Assay Kit (R&D Systems, Minneapolis, MN) was used to determine
the levels of serum cytokines associated with pro- and anti-inflammatory immune
responses. Cytokines assayed included granulocyte-macrophage colony-stimulating
factor (GM-CSF), IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12 p70, IL-13, IL-17A, and
tumor necrosis factor alpha (TNF-α). Serum samples were diluted and a standard curve
was created according to the manufacturer’s protocol. A negative assay control
consisting of calibrator diluent was used to determine the background fluorescence
levels. Serum samples were analyzed on a Magpix instrument with xPONENT software
(R&D Systems, Minneapolis, MN). Cytokine levels were calculated for each analyte
using the respective standard curve. All samples were run in triplicate, and the values
were averaged to provide a mean cytokine level for each respective sample.
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Statistics: Data were analyzed using GraphPad Prism Version 8.2 (GraphPad Software,
San Diego, CA). It was reasoned, a priori, that B. burgdorferi-infected mice depleted of
Treg cells would exhibit greater signs of inflammation than would infected mice not
depleted of Treg cells. The Mann-Whitney U Test (GraphPad Prism) was used to
analyze differences in tibiotarsal joint swelling, arthritis scores, borrelial load, and
cytokine concentrations between infected BALB/c DEREG mice previously administered
DTx or not administered DTx, as well as between infected BALB/c DEREG and BALB/c
WT mice that were previously administered DTx. The alpha level was set at 0.05 prior
to initiation of experiments. Data were expressed as mean ± standard error of the mean
(SEM) unless otherwise stated.
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CHAPTER 3: RESULTS

I. Preliminary Studies
Dose-dependent response to infection with B. burgdorferi in WT BALB/c mice. The
purpose of this experiment was to determine an infectious dose of B. burgdorferi
sufficient to induce moderate disease in BALB/c mice, such that any potential
pathological effects of Treg cell depletion in these mice could be observed. It has been
reported that BALB/c mice exhibit tibiotarsal joint swelling in a dose-dependent manner
when infected with B. burgdorferi (Ma et al. 1998). Mice were injected subcutaneously
between the scapulae with 2X103, 2X104, or 2X105 B. burgdorferi organisms in PBS
supplemented with NMS or with PBS supplemented with NMS alone. No swelling was
observed for the first week following infection in mice infected with 2X10 3 and 2X104
spirochetes, after which time joint swelling steadily increased. Mice infected with 2X103
organisms exhibited a milder degree of tibiotarsal joint swelling (Figure 1), than mice
infected with 2X104 organisms. By contrast, slight tibiotarsal joint swelling was
observed within the first week in mice infected with 2X105 organisms. Joint swelling
continued to increase for the duration of the experiment, ending with a degree of
tibiotarsal joint swelling higher than mice infected with either 2X103 or 2X104 organisms.
No changes in tibiotarsal joint swelling was observed in uninfected mice. No statistically
significant differences were observed between mice infected with the different doses of
B. burgdorferi. However, significant differences in joint swelling were observed between
uninfected mice and mice infected with both 2X104 and 2X105 organisms beginning at
Day 21 and continuing for the duration of the experiment. Based on these results, it
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was determined that an infectious dose of not more than 2X10 3 organisms would be
used to assess the effects of Treg cells on the development and progression of Lyme
disease as Treg cell depletion is expected to worsen disease.

Figure 1: Average changes in tibiotarsal joint swelling in response to
infection with increasing doses of B. burgdorferi. BALB/c WT mice were
infected with either PBS + NMS (n=7) (circles) or, 2X103 (n=4) (squares),
2X104 (n=6) (triangles), or 2X105 (n=6) (cones) spirochetes. Error bars
represent SEM. * P ≤ 0.05. ** P ≤ 0.01. *** P ≤ 0.001. Asterisks denote
statistically significant differences when compared to uninfected BALB/c WT
mice.

Effect of DTx on Treg cell depletion in DEREG mice. Previous studies have
demonstrated that 1 µg of DTx administered for two consecutive days was sufficient for
the rapid depletion of Treg cells (Lahl and Sparwasser 2011). Two different lots of
diphtheria toxin were used for these studies, so it was necessary to compare the activity
of each lot of diphtheria toxin to confirm that their depletion efficiencies were similar. In
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PBS control mice, 2.61% of lymphocytes expressed Foxp3 (Table 1). As expected, the
average percentage of splenic lymphocytes that were positive for Foxp3 was
decreased, but the decrease was similar between mice administered the two lots of
diphtheria toxin, with 0.66% and 0.53% of lymphocytes positive for Foxp3, respectively.
When compared to the average percentage of Foxp3+ cells from mice administered
PBS alone, DTx reduced the average percentages of Foxp3+ lymphocytes by
approximately 75% and 80%, respectively.
Table 1: Toxin effectiveness as determined by flow
cytometric detection of Treg cell percentages. Data
represent average percentage of splenic lymphocytes that
were positive for Foxp3 ± SEM. N=3

Group

% Foxp3+

PBS

2.61 ± 0.01

Lot 1 of DTx

0.66 ± 0.26

Lot 2 of DTx

0.53 ± 0.18

II. Specific Aim 1: Determine the effect of Treg cells on the development of
arthritis following B. burgdorferi infection.
Effect of diphtheria toxin (DTx) on weight in treated mice. Mice were weighed to monitor
potential health effects following diphtheria toxin administration. For one study, the
effects of DTx on mouse weight were determined in mice infected with 1X102 B.
burgdorferi organisms. BALB/c DEREG mice administered PBS, without DTx, and
infected with B. burgdorferi exhibited consistent weight gain for the duration of the 20day experiment (Figure 2). Additionally, no weight loss was observed in BALB/c
DEREG mice administered DTx prior to infection with B. burgdorferi. However, there
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was no steady increase in weight in these mice from days -2 to 5 after infection.
Following this, a slight increase in weight occurred from days 5 to 8 after infection, at
which time the weights remained steady but lower than in infected mice not previously
administered DTx. While changes of weight in BALB/c DEREG mice administered DTx
prior to infection were less than in BALB/c DEREG mice administered PBS prior to
infection, they were not statistically significant. By contrast, an initial weight loss was
observed on the first day following infection in B. burgdorferi-infected BALB/c WT mice
previously administered DTx, with weight decreasing slightly over the next three days.
On day 5 following infection and subsequently thereafter, the mice began to steadily
gain weight. This weight gain was comparable to that observed in BALB/c DEREG
mice administered PBS prior to infection with B. burgdorferi. These weight changes
were greater in BALB/c WT mice administered DTx prior to infection than in BALB/c
DEREG mice administered DTx prior to infection; however, these differences were not
statistically significant. Uninfected BALB/c DEREG mice previously administered DTx
exhibited no weight gain for the first three days following infection. The mice then
gained a modest amount of weight beginning four days after infection, with the weight
remaining relatively unchanged from day twelve and onward following infection.
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Figure 2. Average changes in weight following administration of diphtheria
toxin in mice infected with 1X102 B. burgdorferi. Groups consisted of BALB/c
DEREG mice administered DTx prior to infection with B. burgdorferi (n=4) (circles); B.
burgdorferi-infected BALB/c DEREG mice not previously administered DTx (n=4)
(squares); uninfected BALB/c DEREG mice previously administered DTx (n=3)
(triangles); and BALB/c WT mice administered DTx prior to infection with B.
burgdorferi (n=4) (cones). Error bars represent SEM.

In another study, the effects of DTx on weight were determined in mice infected with
1X103 B. burgdorferi organisms. BALB/c DEREG mice that were administered PBS
prior to infection with B. burgdorferi exhibited consistent weight gain throughout the
course of the 35-day experiment (Figure 3). By contrast, in BALB/c DEREG mice
administered DTx prior to infection with B. burgdorferi, a delay in weight gain was
observed for the first three days following infection. From day 3 until day 11 following
infection, the mice began to exhibit a slight weight gain. A weight loss was observed
from day 11 until day 16, although the changes in weight remained above baseline.
From day 16 until the end of the experiment, these mice exhibited consistent weight
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gain. Although weights in these mice were lower than those observed for BALB/c
DEREG mice administered PBS prior to infection, the differences were not statistically
significant. In addition, BALB/c WT mice administered DTx prior to infection with B.
burgdorferi exhibited a relatively consistent weight gain for the duration of the
experiment, much like the weight gain observed in infected BALB/c DEREG mice
previously administered PBS. The weights observed in BALB/ WT mice administered
DTx prior to infection were greater than those observed in BALB/c DEREG mice
administered DTx prior to infection; however, no statistically significant differences were
observed. By contrast, in uninfected BALB/c DEREG mice administered DTx, an initial
weight loss for the first two days following DTx administration was observed. After the
initial weight loss, the weight returned to baseline levels and remained unchanged until
day 12 after infection. At this point, the weight began to increase for the remainder of
the experiment. Finally, uninfected BALB/c DEREG mice administered PBS exhibited
consistent weight gain for the duration of the experiment.
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Figure 3: Average changes in weight following administration of diphtheria
toxin in mice infected with 1X103 B. burgdorferi. Groups consisted of BALB/c
DEREG mice administered DTx prior to infection with B. burgdorferi (n=7) (circles);
B. burgdorferi-infected BALB/c DEREG mice previously administered PBS (n=8)
(squares); uninfected BALB/c DEREG mice previously administered DTx (n=7)
(triangles); uninfected BALB/c DEREG mice previously administered PBS (n=4)
(diamonds); and BALB/c WT mice administered DTx prior to infection with B.
burgdorferi (n=3) (cones). Error bars represent SEM.

Effect of Treg cell depletion on tibiotarsal joint swelling in B. burgdorferi-infected mice.
Average tibiotarsal joint measurements were obtained to assess edematous changes in
response to infection with B. burgdorferi. In one study, mice were infected with 1X102
spirochetes on the day immediately following the two consecutive days of DTx
administration. A minimal degree of swelling was observed in BALB/c DEREG mice
administered PBS prior to infection with 1X102 organisms (Figure 4). By contrast,
tibiotarsal joint swelling in BALB/c DEREG mice administered DTx prior to infection
increased consistently during the duration of the experiment. The tibiotarsal joint
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swelling in BALB/c DEREG mice administered DTx prior to infection with 1X102
organisms was generally greater than that of BALB/c DEREG administered PBS prior to
infection, approaching statistical significance (P = 0.057) at days 16 and 20 following
infection. In addition, the degree of tibiotarsal joint swelling in BALB/c DEREG mice
administered DTx prior to infection was also consistently greater than that of BALB/c
WT mice administered DTx prior to infection, with statistically significant differences
observed at day eight following infection and continuing for the remainder of the
experiment (P ≤ 0.05). No tibiotarsal joint swelling was observed in uninfected BALB/c
DEREG mice administered DTx.

*
*
*
*

Figure 4. Average swelling changes in tibiotarsal joints of mice infected with 1X102
organisms. Groups consisted of B. burgdorferi-infected BALB/c DEREG mice previously
administered DTx (n=4) (circles); B. burgdorferi-infected BALB/c DEREG mice previously
administered PBS (n=4) (squares); uninfected BALB/c DEREG mice previously administered
DTx (n=3) (triangles); and B. burgdorferi-infected BALB/c WT mice previously administered
DTx (n=4) (cones). Error bars represent SEM. * P ≤ 0.05 and denote a comparison
between B. burgdorferi-infected BALB/c DEREG and WT mice administered DTx. Note: four
lines are present on the graph, but no changes in paw measurements were observed in one
group, so the fourth line overlaps both the third line and the x-axis .
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In another study, the effects of Treg cell depletion were assessed in mice infected with
1X103 organisms. Increased swelling has been observed at increasing infectious doses
(Figure 1; Ma et al. 1998), so it was predicted that similar results would be observed at
an increased infectious dose. In BALB/c DEREG mice administered PBS prior to
infection with B. burgdorferi, changes in tibiotarsal joint swelling were observed on day 8
following infection. This swelling increased steadily until day 28 after infection, at which
point the swelling began to slightly decrease until day 35 following infection (Figure 5).
Tibiotarsal joint swelling was also evident in BALB/c DEREG mice administered DTx
prior to infection. Tibiotarsal joint swelling in these mice also became apparent on day 8
following infection and increased steadily until 32 days after infection before plateauing.
However, no significant differences in tibiotarsal joint swelling were observed between
these groups of mice. Tibiotarsal joint swelling was also observed in BALB/c WT mice
administered DTx prior to infection. Tibiotarsal joint swelling in these mice became
evident on day 8 following infection and continued increasing until day 28 following
infection. Following this, a noticeable decrease in swelling was observed. Tibiotarsal
joint swelling differences between B. burgdorferi-infected BALB/c DEREG and WT mice
previously administered DTx approached statistical significance on day 32 following
infection (P = 0.06) and reached statistical significance on day 35 after infection (P ≤
0.05). No tibiotarsal joint swelling was observed in either uninfected BALB/c DEREG
mice previously administered DTx or in uninfected BALB/c DEREG mice previously
administered PBS.
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Figure 5. Average swelling changes in tibiotarsal joints of mice infected with 1X103
organisms. Groups consisted of B. burgdorferi-infected BALB/c DEREG mice previously
depleted of Treg cells (n=7) (circles); B. burgdorferi-infected BALB/c DEREG mice previously
administered PBS (n=8) (squares); uninfected BALB/c DEREG mice administered DTx (n=7)
(triangles); uninfected BALB/c DEREG mice administered PBS (n=3) (diamonds); and B.
burgdorferi-infected BALB/c WT mice previously administered DTx (n=4) (cones). Error bars
represent SEM. * P ≤ 0.05 and denote a comparison between B. burgdorferi-infected
BALB/c DEREG and WT mice previously administered DTx.

Effect of Treg cell depletion on histopathology of tibiotarsal joints. The effect of Treg cell
depletion on the development of arthritis was assessed in mice infected with 1X102
organisms. Histopathological analysis of the tibiotarsal joints revealed the presence of
minimal arthritic lesions in B. burgdorferi-infected BALB/c DEREG mice previously
administered PBS (Table 2). Additionally, minimal arthritis was found in B. burgdorferiinfected BALB/c DEREG previously administered DTx. No statistically significant
differences were observed between these two groups. Likewise, histopathological
analysis revealed the presence of minimal arthritic lesions in B. burgdorferi-infected
BALB/c WT mice previously administered DTx. No statistically significant differences
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were observed between infected BALB/c DEREG and WT mice previously administered
DTx. No arthritic lesions were observed in uninfected BALB/c DEREG mice
administered DTx.

Table 2: Average pathology scores of tibiotarsal joints in mice infected with
1X102 spirochetes. Groups consisted of B. burgdorferi-infected BALB/c DEREG
mice previously administered PBS (PBS + Bb) (n=4); B. burgdorferi-infected
BALB/c DEREG mice previously depleted of Treg cells (DTx + Bb) (n=4); B.
burgdorferi-infected BALB/c WT mice previously administered DTx (DTx + Bb)
(n=4); and uninfected (PBS + normal mouse serum, NMS) BALB/c DEREG mice
administered DTx (DTx) (n=3). Data presented as average scores ± SEM.

Genotype

DTx

Infection

Avg. Pathology
Score

DEREG

PBS

Bb

0.33 ± 0.33

DEREG

DTx

Bb

0.50 ± 0.29

WT

DTx

Bb

0.25 ± 0.25

DEREG

DTx

PBS + NMS

0±0

The effect of Treg cell depletion on the development of arthritis was also assessed in
mice infected with 1X103 organisms. Histopathological analysis of the tibiotarsal joints
in B. burgdorferi-infected BALB/c DEREG mice previously administered PBS revealed
the presence of minimal arthritic lesions (Table 3). By contrast, two to three small foci
of inflammation were observed in multiple B. burgdorferi-infected BALB/c DEREG mice
previously administered DTx. However, no statistically significant pathological
differences were observed between these mice. Additionally, no arthritic lesions were
detected in B. burgdorferi-infected BALB/c WT mice previously administered DTx, and
no statistically significant differences were observed between these WT mice and
infected BALB/c DEREG mice previously administered DTx. No arthritis was detected
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in either uninfected BALB/c DEREG mice previously administered DTx or in uninfected
BALB/c DEREG mice previously administered PBS.
Table 3: Average pathology scores of tibiotarsal joints in mice infected with 1X10 3
spirochetes. Groups consisted of B. burgdorferi-infected BALB/c DEREG mice previously
administered PBS (Bb + PBS) (n=8); B. burgdorferi-infected BALB/c DEREG mice
previously depleted of Treg cells (DTx + Bb) (n=7); B. burgdorferi-infected BALB/c WT mice
previously administered DTx (DTx + Bb) (n=4); uninfected BALB/c DEREG mice
administered DTx (DTx + PBS + NMS) (n=7); and uninfected BALB/c DEREG mice
administered PBS (PBS + PBS/NMS) (n=3). Data presented as average scores ± SEM.
Note: one extreme outlying point was excluded from uninfected DEREG mice previously
administered DTx (DTx + PBS/NMS). Removal of this point did not affect the statistical
analysis.

Genotype

DTx

Infection

Avg. Pathology
Score

DEREG

PBS

Bb

0.13 ± 0.13

DEREG

DTx

Bb

0.71 ± 0.36

WT

DTx

Bb

0±0

DEREG

DTx

PBS + NMS

0.17 ± 0.17

DEREG

PBS

PBS + NMS

0±0

III. Specific Aim 2: Determine the effect of Treg cells on the control of the immune
response following infection with B. burgdorferi
Effect of Treg cell depletion on bacterial load in tibiotarsal joint tissue of infected mice.
qPCR analysis was used to quantify the levels of B. burgdorferi in the tibiotarsal joints
obtained from infected mice previously administered DTx to assess the impact of Treg
cells on the ability of the immune system to control dissemination of organisms. In one
study, in mice infected with 1X102 organisms, the bacterial load was assessed at 20
days following infection. No spirochetes were detected in B. burgdorferi-infected
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BALB/c DEREG mice previously administered PBS (Figure 6). By contrast, the levels of
B. burgdorferi in the tibiotarsal joints of infected BALB/c DEREG mice previously
administered DTx was greater than those found in B. burgdorferi-infected BALB/c
DEREG mice administered PBS, but were low, overall; however, this increase was not
statistically significant. Lower levels of B. burgdorferi were detected in BALB/c WT mice
administered DTx prior to infection than in BALB/c DEREG mice administered DTx prior
to infection; however, this difference was also not statistically significant. No
spirochetes were detected in uninfected BALB/c DEREG mice administered DTx.

Figure 6. Borrelial load in tibiotarsal joint tissue of mice infected with
1X102 organisms. Groups consisted of BALB/c DEREG mice administered
PBS prior to infection with B. burgdorferi (Bb) (n=4); BALB/c DEREG mice
administered DTx prior to infection with B. burgdorferi (DTx + Bb) (n=4); B.
burgdorferi-infected BALB/c WT mice previously administered DTx (WT) (n=4);
and uninfected BALB/c DEREG mice previously administered DTx (DTx) (n=3).
Data presented as average borrelial genomes (RecA) per 104 mouse
genomes. Error bars represent SEM.
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In another study, bacterial load was assessed in the tibiotarsal joints of mice infected
with 1X103 organisms at 35 days following infection. Low levels of spirochetes were
detected in B. burgdorferi-infected BALB/c DEREG mice previously administered PBS
(Figure 7). The levels of B. burgdorferi in infected BALB/c DEREG mice previously
administered DTx were similar to those observed in infected BALB/c DEREG mice
previously administered PBS, with no statistically significant differences between the
two groups. Similarly, the levels of spirochetes detected in infected BALB/c WT mice
previously administered DTx were comparable to those observed in infected BALB/c
DEREG mice previously administered DTx, also with no statistically significant
differences occurring between these two groups. No spirochetes were detected in
either uninfected BALB/c DEREG mice previously administered DTx or in uninfected
BALB/c DEREG mice previously administered PBS.
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Figure 7. Borrelial load in tibiotarsal joint tissue of mice infected with 1X103
organisms. Experimental groups consisted of BALB/c DEREG mice administered
PBS prior to infection with B. burgdorferi (Bb) (n=8); BALB/c DEREG mice
administered DTx prior to infection with B. burgdorferi (DTx + Bb) (n=6); B.
burgdorferi-infected BALB/c WT mice previously administered DTx (WT) (n=4);
uninfected BALB/c DEREG mice previously administered DTx (DTx) (n=7); and
uninfected BALB/c DEREG mice previously administered PBS (PBS + NMS) (n=3).
Data is presented as average borrelial genomes (RecA) per 104 mouse genomes.
Error bars represent SEM.
Note: one extreme outlying data point (406 RecA/10^4 mouse genomes) was
removed from the DTx + Bb group. Removal of this point did not affect the statistical
analysis.

Effect of Treg cell depletion on bacterial load in heart tissue of infected mice
administered DTx. qPCR analysis was also used to quantify the levels of B. burgdorferi
in the heart tissue obtained from infected mice previously administered DTx. In mice
infected with 1X102 organisms, the bacterial load was assessed at 20 days following
infection. Few spirochetes were detected in B. burgdorferi-infected BALB/c DEREG
mice administered PBS (Figure 8). The levels of B. burgdorferi in the heart tissue of
infected BALB/c DEREG mice previously administered DTx was similar to that found in
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B. burgdorferi-infected BALB/c DEREG mice previously administered PBS, with no
statistically significant differences observed between these two groups. By contrast, no
spirochetes were detected in infected BALB/c WT mice previously administered DTx;
however, no statistically significant difference was observed between these mice and
infected BALB/c DEREG mice previously administered DTx. No spirochetes were
detected in uninfected BALB/c DEREG mice administered DTx.

Figure 8. Borrelial load in heart tissue of mice infected with 1X102
organisms. Groups consisted of BALB/c DEREG mice administered PBS prior
to infection with B. burgdorferi (Bb) (n=4); BALB/c DEREG mice administered
DTx prior to infection with B. burgdorferi (DTx + Bb) (n=4); B. burgdorferiinfected BALB/c WT mice previously administered DTx (WT) (n=4); and
uninfected BALB/c DEREG mice previously administered DTx (DTx) (n=3).
Data presented as average borrelial genomes (RecA) per 104 mouse genomes.
Error bars represent SEM.

In another study, bacterial load was assessed in the heart tissue of mice infected with
1X103 organisms at 35 days following infection. Few spirochetes were detected in B.
burgdorferi-infected BALB/c DEREG mice previously administered PBS (Figure 9). By

40

contrast, the levels of B. burgdorferi in infected BALB/c DEREG mice previously
administered DTx were significantly greater than those observed in infected BALB/c
DEREG mice previously administered PBS (P ≤ 0.01); however, the borrelial load in
these mice was still relatively small. In addition, levels of spirochetes detected in
infected BALB/c WT mice previously administered DTx were significantly lower than
those of infected BALB/c DEREG mice previously administered DTx (P ≤ 0.05). No
spirochetes were detected in either uninfected BALB/c DEREG mice previously
administered DTx or in uninfected BALB/c DEREG mice previously administered PBS.

Figure 9. Borrelial load in heart tissue of mice infected with 1X103
organisms. Experimental groups consisted of BALB/c DEREG mice administered
PBS prior to infection with B. burgdorferi (Bb) (n=8); BALB/c DEREG mice
previously administered DTx prior to infection with B. burgdorferi (DTx + Bb)
(n=6); B. burgdorferi-infected BALB/c WT mice previously administered DTx (WT)
(n=4); uninfected BALB/c DEREG mice previously administered DTx (DTx) (n=7);
and uninfected BALB/c DEREG mice previously administered PBS (PBS +
PBS/NMS) (n=3). Data is presented as average borrelial genomes (RecA) per
104 mouse genomes. Error bars represent SEM. * P-values ≤ 0.05. ** P-value ≤
0.01.
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Effect of Treg cell depletion on cytokine levels in serum. A multiplex cytokine assay was
used to determine the concentration of twelve cytokines in the serum of B. burgdorferiinfected DEREG mice previously administered diphtheria toxin or not administered
diphtheria toxin. The majority of cytokines analyzed were not detected in the serum
samples (data not shown); however, IL-4, IL-5, and IL-10 were detected at
concentrations that fell within the range of the respective standard curves for each
cytokine. IL-4 was the most abundant cytokine detected in the serum of all groups of
mice. The concentration of IL-4 in B. burgdorferi-infected BALB/c DEREG mice
previously administered PBS tended to be higher than the concentration detected in B.
burgdorferi-infected BALB/c DEREG mice previously administered DTx; however, this
difference was not statistically significant (Figure 10A). Additionally, the concentration
of IL-4 was also similar in infected BALB/c DEREG and WT mice previously
administered DTx, with no statistically significant difference between these two groups.
The concentrations of IL-4 in uninfected BALB/c DEREG mice previously administered
DTx or not previously administered DTx were comparable to those observed in infected
BALB/c DEREG mice previously administered PBS. By contrast, in naïve mice, which
were mice that had not been subjected to any treatments during the experiment, the
highest concentration of IL-4 was detected. None of these differences were statistically
significant.

IL-5 also was detected in the serum of all groups of mice. The concentration of IL-5 in
B. burgdorferi-infected BALB/c DEREG mice previously administered PBS was lower
than the concentration detected in B. burgdorferi-infected BALB/c DEREG mice

42

previously administered DTx; however, this difference was not statistically significant
(Figure 10B). Additionally, the concentration of IL-5 in infected BALB/c DEREG mice
previously administered DTx was higher than that detected in infected BALB/c WT mice
previously administered DTx; however, no statistically significant difference was
observed between these two groups. By contrast, in uninfected BALB/c DEREG mice
previously administered DTx, the concentration of IL-5 tended to be greater than all
other groups. In uninfected BALB/c mice previously administered PBS, the
concentration of IL-5 observed in the serum tended to be lower than all other groups. A
comparable concentration of IL-5 was detected in naïve mice and both infected BALB/c
DEREG mice previously administered PBS and infected BALB/c WT mice previously
administered DTx.

IL-10 was also detected in the serum of mice. The concentration of IL-10 in B.
burgdorferi-infected BALB/c DEREG mice previously administered PBS was slightly
lower than that detected in B. burgdorferi-infected BALB/c DEREG mice previously
administered DTx; however, this difference was not statistically significant (Figure 10C).
By contrast, the concentration of IL-10 in infected BALB/c DEREG mice administered
DTx prior to infection was significantly higher than that detected in infected BALB/c WT
mice previously administered DTx (P ≤ 0.05). No IL-10 was observed in the serum of
uninfected BALB/c DEREG mice previously administered DTx. Slightly lower
concentrations of IL-10 were observed in uninfected BALB/c DEREG mice previously
administered PBS than in BALB/c DEREG mice administered PBS prior to infection.
Minimal IL-10 was observed in naïve mice.
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Figure 10. IL-4 (A), IL-5 (B), and IL-10 (C) concentrations detected in serum
of either uninfected or infected mice not administered DTx or administered
DTx. Groups consisted of BALB/c DEREG mice administered PBS prior to
infection with B. burgdorferi (Bb) (n=8); BALB/c DEREG mice depleted of Treg
cells prior to infection with B. burgdorferi (DTx + Bb) (n=7); B. burgdorferi-infected
BALB/c WT mice administered DTx (WT: DTx + Bb) (n=4); uninfected BALB/c
DEREG mice administered DTx (DTx) (n=7); uninfected BALB/c DEREG mice
administered PBS (PBS + PBS/NMS) (n=3); and untreated naïve mice (naïve)
(n=3). Data presented as average concentration (pg/mL) of cytokine per group.
Error bars represent SEM. * P-values < 0.05.
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CHAPTER 4: DISCUSSION

Little evidence exists of the role of Treg cells within the context of the development and
progression of Lyme disease. Additionally, little evidence exists of the role of Treg cells
in the control of the immune response to infection with B. burgdorferi. The objective of
this thesis was to determine the role of Treg cells in the development and progression of
Lyme disease in a disease-susceptible mouse model. We hypothesized that Treg cells
control the development and progression of Lyme disease following B. burgdorferi
infection. To test this hypothesis, the first specific aim was to determine the effect of
Treg cells on the development of arthritis following infection with B. burgdorferi, with the
working hypothesis that depletion of Treg cells will exacerbate tibiotarsal joint swelling
and arthritis. The second specific aim pursued was to determine the effect of Treg cells
on the control of the immune response following infection with B. burgdorferi, with the
working hypothesis that depletion of Treg cells will result in an increased ability to
control bacterial dissemination and increased levels of pro-inflammatory cytokines
following B. burgdorferi infection. We demonstrated that depletion of Treg cells
immediately prior to infection of BALB/c mice with B. burgdorferi led to significantly
increased edema in the tibiotarsal joints of mice infected with a low dose of organisms
(Figures 4 and 5), with indications of increased arthritis among some mice (Table 3).
We also demonstrated that Treg cell depletion affected the ability of the immune system
to prevent bacterial dissemination as higher levels of B. burgdorferi were observed in
tissues of mice that had been administered diphtheria toxin prior to infection (Figures 6
and 9) .
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All studies, with the exception of the preliminary experiment, were conducted using the
“depletion of regulatory T cell”, or DEREG, mouse model on the BALB/c background.
The DEREG mouse strain has been engineered to express a fusion protein comprised
of a diphtheria toxin receptor and an enhanced green fluorescent protein which is under
the control of the foxp3 promoter (Lahl et al. 2007). As Foxp3 is regarded as the
definitive marker for identification of Treg cells (Fontenot et al. 2003), this mouse model
allows for the selective depletion of Treg cells via administration of small amounts of
diphtheria toxin. In fact, the vast majority of Foxp3+ Treg cells are depleted with two
consecutive days of injection with 1 µg of DTx (Lahl and Sparwasser 2011), thus
enabling researchers to study the role of Treg cells in a variety of diseases. In support
of this, we assessed the Treg cell depletion efficiency the day after two consecutive
days of administration of two lots of DTx. The two lots of DTx reduced the amounts of
Foxp3+ cells by approximately 75% and 80%, respectively (Table 1). BALB/c WT mice,
in which diphtheria toxin would have no effect on Treg cells, were used as additional
controls. It was expected that these BALB/c WT mice would exhibit disease in a
manner similar to BALB/c DEREG mice infected with B. burgdorferi and administered
PBS alone. This hypothesis was supported by the observation of similar trends in
tibiotarsal joint swelling, arthritis development, borrelial loads, and serum cytokine
profiles, with no significant differences observed between these two groups.

Weight changes were recorded during all studies involving the use of diphtheria toxin.
A common side effect of injection with small amounts of diphtheria toxin is transient
weight loss (Mayer et al. 2014). BALB/c WT mice allowed for the monitoring of potential
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toxicity induced by injection of diphtheria toxin. A delay in weight gain and, in some
instances, transient weight loss were observed in all mice administered diphtheria toxin,
whereas mice not administered diphtheria toxin exhibited consistent weight gain for the
duration of the experiments (Figures 2 and 3). Any weight loss occurred immediately
following administration of the toxin, and then the mice began to gain weight within a
week following injection. This trend was similar across all mice that had been
administered diphtheria toxin regardless of genotype. This finding was corroborated by
previous studies using DEREG mice in our lab, in which similar trends were observed in
C57BL/6 DEREG mice following diphtheria toxin administration (Nardelli et al.
unpublished data). This observation suggested that any effects observed in the disease
severity of B. burgdorferi-infected DEREG mice administered diphtheria toxin would be
due to the effects of Treg cell depletion on infection and not due to any adverse health
effects associated with diphtheria toxin administration. This was also corroborated by
the lack of tibiotarsal joint swelling observed in uninfected BALB/c DEREG mice
administered DTx (Figures 4 and 5).

In one study, BALB/c DEREG mice were administered DTx prior to infection with 1X102
spirochetes, with a group of BALB/c DEREG mice administered PBS prior to infection
serving to demonstrate the normal progression of infection in the presence of Treg cells.
Based on timing of the appearance of tibiotarsal joint swelling in the preliminary
experiment (Figure 1), 20 days following infection was chosen as the experimental end
point. Ma et al. (1998) showed that WT BALB/c mice infected with 2X102 spirochetes
did not previously exhibit ankle joint swelling; therefore, it was predicted that infection
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with this dose may allow for visualization of any effects of Treg cell depletion on
disease. Here, in BALB/c DEREG mice administered PBS prior to infection with 1X10 2
spirochetes, no edematous changes in the tibiotarsal joint were also observed.
Additionally, no tibiotarsal joint swelling was observed in infected WT mice previously
administered DTx. By contrast, joint swelling was apparent in B. burgdorferi-infected
BALB/c DEREG mice previously administered DTx (Figure 4). The difference in joint
swelling between infected DEREG and WT mice previously administered DTx was
statistically significant from Day 8 through Day 20 following infection (Figure 4, P ≤
0.05). Additionally, the differences in paw swelling between BALB/c DEREG mice
depleted of Treg cells prior to infection and infected BALB/c DEREG mice not previously
depleted of Treg cells approached statistical significance by days 16 and 20 following
infection (P = 0.057). It is possible that statistical significance was not achieved
between these two groups because one mouse that had been administered PBS prior
to infection exhibited a minimal degree of tibiotarsal joint swelling. Our findings that
depletion of Treg cells increased tibiotarsal joint swelling in B. burgdorferi-infected
BALB/c mice are supported by previous studies in our lab. Our lab demonstrated that
depletion of Treg cells in infected, Lyme arthritis-resistant C57BL/6 mice also led to
significantly greater paw swelling than B. burgdorferi-infected C57BL/6 mice
administered PBS alone (Nardelli et al. unpublished data). These findings also provide
support for use of the DEREG mouse model, since the differences in tibiotarsal joint
swelling observed between infected BALB/c WT mice and the BALB/c DEREG mice
administered DTx were due to the specific depletion of the Treg cells that occurred in
the DEREG mice and not due to differences in weight loss.
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Hind paw swelling is not necessarily indicative of arthritis but is instead more indicative
of edema associated with the inflammatory response (Ma et al. 1998). However,
tibiotarsal joint swelling has occasionally been correlated with the development of
arthritis, with increased paw swelling corresponding to arthritis severity (Glickstein et al.
2001). Based on the paw swelling data obtained from mice infected with 1X10 2
organisms, it was expected that the depletion of Treg cells would lead to the
development and increased severity of Lyme arthritis. However, pathological
assessment of the tibiotarsal joints in mice infected with 1X102 spirochetes did not
reveal the presence of arthritic lesions in any of the infected mice (Table 2). This finding
was unexpected given the substantially increased paw swelling observed in the mice
depleted of Treg cells. Although unexpected, these findings may be supported by Ma et
al. (1998), in which arthritis development was not observed in BALB/c mice infected with
2X102 organisms at 28 days following infection. It is possible that, even though paw
swelling was observed in this study, 1X102 organisms may have been too low of a dose
of organisms to elicit a pathological response, even in the absence of Treg cells.
Additionally, it is possible that as disease progressed and inflammation continued in the
tibiotarsal joint tissue, that arthritis would begin to develop with a longer experimental
duration. Twenty days may not have been long enough for arthritis to develop.

We and others have demonstrated that tibiotarsal joint swelling increases with
increasing infectious doses of B. burgdorferi in BALB/c mice (Figure 1; Ma et al. 1998).
In another study, 1X103 B. burgdorferi organisms were used and 35 days was chosen
as the experimental end point to assess the effects of Treg cell depletion. Infection of
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BALB/c mice with 1X103 organisms has been shown to induce a mild degree of
tibiotarsal joint swelling (Figure 1; Ma et al. 1998). We predicted that mice infected with
1X103 organisms would also exhibit paw swelling, with depletion of Treg cells leading to
increased edematous changes and the development of arthritis. However, at the
infectious dose of 1X103 B. burgdorferi, there were no statistically significant differences
observed in tibiotarsal joint swelling between infected BALB/c DEREG mice previously
administered PBS and infected BALB/c DEREG mice administered DTx, although the
degree of swelling eventually was slightly greater in the DEREG mice depleted of Treg
cells. We observed that the joint swelling in infected mice previously depleted of Treg
cells continued to increase throughout the duration of the experiment, whereas the joint
swelling of infected mice not depleted of Treg cells began to subside by the end of the
experiment. In addition, the swelling differences observed between infected BALB/c
DEREG mice previously administered DTx and infected BALB/c WT mice previously
administered DTx was greater and approached statistical significance by Day 32 (P =
0.06), reaching statistical significance by day 35 (P ≤ 0.05) following infection (Figure 5).
Therefore, Treg cells also appeared to control the development of swelling in BALB/c
mice infected with 1X103 B. burgdorferi, although not to the degree that was observed
at the lower infectious dose.

Based on the degree of swelling observed in mice infected with 1X103 organisms, we
predicted that these mice would develop mild arthritis, with depletion of Treg cells
resulting in increased arthritis severity. Pathological analysis revealed the presence of
two to three small foci of inflammation in the tibiotarsal joints of some BALB/c DEREG
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mice depleted of Treg cells prior to infection with B. burgdorferi, with little pathology
observed in other mice belonging to this group. By contrast, no arthritic lesions were
detected in other groups of mice (Table 3). It has been demonstrated that the degree of
tibiotarsal joint swelling in BALB/c mice infected with 1X103 B. burgdorferi is mild (Figure
1). In addition, arthritis that develops in BALB/c mice infected with 2X103 organisms
was also demonstrated to be mild (Ma et al. 1998). In general, BALB/c mice have been
regarded as resistant to the development of Lyme arthritis as infection with 1X106 or
1X107 organisms led to the development of only mild to moderate arthritis (Barthold et
al. 1990). Subsequent studies have, however, demonstrated that arthritis development
can be seen in BALB/c mice infected with lower doses of B. burgdorferi, including 2X104
and 2X105 organisms (Ma et al. 1998). Despite the increase in severity of arthritis
observed by Ma et al, and despite the swelling observed with this infectious dose, these
findings suggest that 1X103 organisms may also not have been sufficient to fully
observe effects of Treg cell depletion on development and severity of arthritis.
However, we observed the development of moderate arthritis in approximately 30% of
BALB/c DEREG mice depleted of Treg cells prior to infection with 1X103 B. burgdorferi.
This provides an indication that Treg cells may, indeed, be involved in inhibiting the
development of actual pathology in these mice.

Collectively, our findings provide partial support for a role for Treg cells in the
development and progression of Lyme disease. Although arthritis severity was not
significantly worsened by ablation of Treg cells immediately prior to infection, the
significantly increased joint swelling observed in BALB/c DEREG mice depleted of Treg
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cells prior to infection with B. burgdorferi does provide support for the hypothesis. In our
lab, depletion of Treg cells in C57BL/6 mice, a mouse genotype normally resistant to the
development of arthritis, led to significantly increased paw swelling and differences in
arthritis development approaching statistical significance (Nardelli et al. unpublished
data). In initial experiments using BALB/ c mice, a more disease-susceptible mouse
strain and low infectious doses, we provide evidence that Treg cells likely influence the
development of joint swelling due to B. burgdorferi infection. We also began to observe
the development of pathology among individual Treg cell-depleted, infected mice as we
increased the infectious dose. The difference in results could potentially be attributed to
the different mouse strains used. Previous studies in our lab were conducted using
C57BL/6 mice, whereas these studies were conducted using BALB/c mice. Although
both mouse models have been regarded as arthritis resistant, studies have
demonstrated that these mouse models respond differently to infection with B.
burgdorferi. It has been reported that the arthritis resistance in BALB/c mice can be
overcome by high doses of inoculum, thereby leading to a disease phenotype more
comparable to that seen in the highly susceptible C3H mouse (Ma et al. 1998). By
contrast, disease severity was consistently mild in C57BL/6 mice, even when higher
doses of inoculum had been used (Barthold et al. 1990; Ma et al. 1998), providing
support for C57BL/6 mice as being a more Lyme disease resistant model than BALB/c
mice. It has been postulated that these differences in response to infection are a result
of inherent immunological differences present in these two mouse strains.
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It is widely accepted that C57BL/6 mice are genetically biased towards a type 1 immune
response, characterized by development of Th1 cells and secretion of their effector
cytokines, such as IFN-γ. Conversely, BALB/c mice are predisposed towards
development of a type 2 immune response, which is characterized by proliferation of
Th2 cells and secretion of their effector cytokines, such as IL-4 (Watanabe et al. 2004).
The differences observed in the effect of Treg cell depletion on Lyme disease in these
two mouse strains could be explained by their respective genetic biases towards one
type of immune response. Treg cells may impact Th1 and Th2 cells differently. For
example, one study suggested that Th2 cells are less susceptible to suppression by
CD4+CD25+ putative Treg cells than Th1 cells (Cosmi et al. 2004). This finding could
explain why a more profound effect of Treg cell depletion was observed in C57BL/6
mice than in the BALB/c mice. The Th2 bias of BALB/c mice may not allow them to be
as susceptible to suppression by Treg cells, so when the Treg cells were removed, no
difference in disease severity was observed. Additionally, the differences observed in
the effect of Treg cell depletion in these two mouse strains could be attributed to the
infectious dose used. An infectious dose of 2X104 B. burgdorferi organisms was used
in the C57BL/6 mice (Nardelli et al. unpublished data), which was considerably higher
than the infectious doses of 1X102 and 1X103 organisms used in these studies.

The lack of functional Treg cells can lead to a dysregulated immune response,
contributing to the pathogenesis of various autoimmune diseases (Sakaguchi et al.
2008); therefore, we also assessed the effect of Treg cell depletion on the immune
response to infection with B. burgdorferi. The borrelial load in tibiotarsal joint tissue and
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heart tissue was quantified as one measure of the effect of Treg cell depletion on the
immune response to infection.

At the infectious dose of 1X102 organisms, the levels of

B. burgdorferi found in infected DEREG mice previously administered DTx were slightly
greater in the tibiotarsal joint than either infected DEREG mice not previously
administered DTx or infected WT mice previously administered diphtheria toxin (Figure
6). Additionally, in the ankle joints of all groups of mice infected with either 1X10 2 or
1X103 organisms, the borrelial load appeared to corroborate the tibiotarsal joint swelling
results, with higher levels of spirochetes correlating with the increased joint swelling. In
the heart tissue of mice infected with 1X102 organisms, no differences in borrelial load
were observed between infected DEREG mice administered DTx and either infected
DEREG mice administered PBS or infected WT mice administered PBS (Figure 8).
However, in the heart tissue of mice infected with 1X103 organisms, the levels of B.
burgdorferi found in DEREG mice administered DTx prior to infection were greater than
the levels observed in the heart tissue of either infected DEREG mice previously
administered PBS or infected WT mice previously administered DTx, with statistically
significant differences between infected DEREG mice previously administered DTx and
infected mice previously administered PBS (Figure 9; P ≤ 0.01) and also between
infected DEREG mice administered DTx and infected WT mice previously administered
DTx (Figure 9; P ≤ 0.05). The increased levels of B. burgdorferi detected in infected
DEREG mice previously administered DTx suggest that the depletion of Treg cells may
potentially affect the immune system’s ability to clear B. burgdorferi, thereby allowing
the organism to disseminate throughout the body.
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Cells of the innate immune system, such as neutrophils and macrophages have been
shown to be involved in phagocytosis and killing of B. burgdorferi and have been
observed in areas of inflammation (Benach et al. 1984; Barthold et al. 1991).
Additionally, B cells have been shown to be responsible for the resolution of Lyme
arthritis and carditis (McKisic and Barthold 2000). Specifically, a robust B cell response
has been shown to result in a more rapid resolution of disease (Blum et al. 2018).
BALB/c mice are believed to generate a strong B cell response to infection with B.
burgdorferi (Glickstein et al. 2001). It has also been suggested that borreliacidal
antibody production is important for protection against B. burgdorferi, as presence of
these antibodies correlates with elimination of spirochetes from tissues (Creson et al.
1996). The primary mechanism by which Treg cells control the immune response is
secretion of anti-inflammatory cytokines. It has been suggested that secretion of TGF-β
by Treg cells affects the proliferation of T and B cells, and also affects the activity of
macrophages, dendritic cells, and natural killer cells (Yoshimura et al. 2010). It is
possible that depletion of Treg cells would lead to decreased production of TGF-β,
which would increase the proliferation of innate immune cells and the production of
antibodies. Theoretically, this increase in cells should then lead to a more robust
immune response to infection with B. burgdorferi, thereby preventing the dissemination
of spirochetes. However, B. burgdorferi has been shown to induce the production of the
anti-inflammatory cytokine IL-10 by innate host cells (Giambartolomei et al. 1998; Brown
et al. 1999; Ganapamo et al. 2003). Instead of the possibly increased numbers of
innate cells contributing to spirochete control, depletion of Treg cells could possibly lead
to the secretion of more IL-10 by these cell types. Increased levels of IL-10 would then
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act to suppress the initial inflammatory response, thus allowing B. burgdorferi to evade
destruction and migrate to other tissues. This could explain the increased
concentrations of B. burgdorferi observed in the tibiotarsal joint of mice infected with
1X102 organisms and the heart tissue of mice infected with 1X103 organisms that were
depleted of Treg cells (Figures 6 and 9). Even though the infectious doses were low,
the organisms were able to disseminate, also causing the increased joint swelling
observed in these mice (Figures 4 and 5).

Studies in other models of infection have also demonstrated that Treg cell depletion
affects the clinical outcomes of disease. A protective role for Treg cells has been
demonstrated in some virally infected mice (Lund et al. 2008; Lanteri et al. 2009), some
parasitic infections (Oldenhove et al. 2009; Haque et al. 2010), and some fungal
infections (Pandiyan et al. 2011) as ablation of Treg cells in these infected mice have
led to increased viral, parasitic, and fungal loads. Conversely, a detrimental role for
Treg cells has been shown in other bacterial infections, such as Listeria monocytogenes
and Salmonella enterica. In these infections, it was demonstrated that depletion of Treg
cells resulted in decreased pathogen burden (Johanns et al. 2010; Rowe et al. 2011).
Based on the assessment of borrelial load, Treg cells may serve a protective role in B.
burgdorferi infection, as depletion of these cells led to increased borrelial load in both
tibiotarsal joint and heart tissue. Further studies are needed to support this hypothesis.

The levels of B. burgdorferi found in both the joint and heart tissue were found to be
relatively low; however, this may have been expected due to the low infectious dose
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used for both studies. Additionally, the route of infection could potentially impact the
course of disease. It has been suggested that BALB/c mice infected with B. burgdorferi
directly into the footpad readily develop arthritis (Motameni et al. 2005). For our studies,
mice were infected subcutaneously between the scapulae, so the bacteria had to
disseminate to the joint tissue. It has been demonstrated that B. burgdorferi
disseminate to areas more proximal to the site of inoculation, with fewer spirochetes
travelling to distal sites (Motameni et al. 2005). However, many studies involved
infecting mice intradermally at a site removed from the location of pathology as a way to
model the bacterial dissemination that would occur in humans following a tick bite.
BALB/c mice infected in this manner have also developed arthritis, but the infectious
doses have been higher than those used in our studies (Barthold et al. 1990; Barthold et
al. 1991; de Souza et al. 1993; Yang et al. 1994; Ma et al. 1998). The route of infection
could impact disease outcomes in combination with the infectious dose. At these lower
infectious doses, it is plausible that fewer spirochetes were able to disseminate from the
site of infection, especially to the joint tissue; therefore, arthritis development generally
was not observed. It is possible that more spirochetes disseminated to the heart tissue.
Additionally, the levels of B. burgdorferi in both tissues appeared to be dependent upon
the infectious dose used, as lower levels tended to be detected in mice infected with
1X102 organisms than in mice infected with 1X103 organisms (Figures 6-9). It has been
suggested that severity of disease corresponds to the numbers of spirochetes within
tissues, with persistence of higher numbers of spirochetes within the joint tissue
corresponding to increased severity of Lyme arthritis (Yang et al. 1994). By contrast, in
mice deficient for IL-10, fewer spirochetes were detected in joint tissue, but increased
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arthritis severity was observed (Brown et al. 1999), suggesting that disease severity
may not necessarily correlate with spirochete presence in tissues. Interestingly, B.
burgdorferi stimulates the production of IL-10 early in response to infection
(Giambartolomei et al. 1998; Brown et al. 1999; Ganapamo et al. 2003); therefore, it is
possible that Treg cell depletion leads to increased numbers of innate immune cells,
which increases the secretion of IL-10 in response to infection. This hypothesis is
supported by the increased numbers of spirochetes detected in joint and heart tissue of
B. burgdorferi-infected DEREG mice depleted of Treg cells (Figures 6-9).

To further determine the effect of Treg cell depletion on the immune response following
B. burgdorferi infection, multiplex cytokine analysis was performed to determine the
concentrations of various pro- and anti-inflammatory cytokines in mouse serum. As
some pro-inflammatory cytokines have been implicated in the pathogenesis of Lyme
arthritis, it was predicted that depletion of Treg cells would lead to increased
concentrations of pro-inflammatory cytokines. Of particular interest were cytokines
associated with Th1 and Th17 cells, namely IFN-γ and IL-17, respectively. IFN-γ (Yssel
et al. 1991; Gross et al. 1998) and IL-17 (Codolo et al. 2013) were of particular interest
due to their role in pathogenesis of Lyme arthritis in humans. Neither of these cytokines
were detected in the serum of mice at concentrations that fell within the range of their
respective standard curves (data not shown). It is possible that IFN-γ was not detected
in BALB/c mice because it has been suggested that a Th1 response occurs earlier
during the course of infection, with the Th1 immune response transitioning over to a
Th2-dominated response approximately two weeks after infection (Kang et al. 1997).
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Additionally, IFN-γ does not appear to be required for resistance to Lyme arthritis;
however, ablation of IFN-γ does promote generation of a Th2 response over a Th1
response (Glickstein et al. 2001). It is also possible that the immunological bias of a
Th2 immune response in BALB/c mice may prevent the development of a Th1-mediated
response, as cytokines secreted by Th2 cells act as negative regulators of a Th1
response, thereby preventing differentiation of Th1 cells (Fishman and Perelson 1994).
The low amount of pro-inflammatory cytokines detected in these mice could explain the
overall lack of arthritis development. IL-4, IL-5, and IL-10 were, however, detected in
the serum samples at concentrations within the ranges of their respective standard
curves, providing further support for the inherent Th2 bias present in these mice.

IL-10 was one of the cytokines detected in mouse serum. IL-10 is an anti-inflammatory
cytokine produced by a variety of cell types, with Treg cells being the most abundant
source (Arce-Sillas et al. 2016). The role of IL-10 has been studied within the context of
Lyme disease; however, many of these studies have been conducted in C57BL/6 mice,
as IL-10 is believed to be an important contributing factor to resistance in this mouse
model. A study conducted by Brown et al. (1999) demonstrated that IL-10 deficiency in
C57BL/6 mice resulted in increased severity of arthritis, but decreased numbers of
spirochetes in the joint tissue (Brown et al. 1999). A possible mechanism of regulation
is that IL-10 leads to decreases in the inflammatory Th17 cell responses (Hansen et al.
2013), suggesting that IL-10 is responsible for the regulation of arthritis severity in the
Lyme disease-resistant mouse model. Surprisingly, the highest level of IL-10 was
observed in infected DEREG mice previously administered DTx. When compared to
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infected WT mice previously administered DTx, the difference was statistically
significant. In the DEREG mouse model, Treg cells begin to rebound approximately
four days after depletion, with a complete rebound achieved by fourteen days after
depletion (Lahl and Sparwasser 2011). It is possible that the increased levels of IL-10
detected in the serum of infected mice previously depleted of Treg cells could be a
result of overcompensation of Treg cells as they rebounded in an attempt to regain
control of the immune response to infection. It is possible that IL-10, in conjunction with
IL-4, may serve to contribute to the regulation of disease severity in BALB/c mice.
However, Treg cells are not the only source of IL-10. It is possible that the IL-10
observed in serum did not originate from Treg cells, but instead may have originated
from the Th2 cells as part of a regulatory mechanism to prevent the differentiation of
Th1 cells (Moore et al. 2001).

IL-5, another Th2 cytokine, was also detected in mouse serum. The primary function of
IL-5 is to promote the differentiation and survival of eosinophils (Borish et al. 2003;
Straumann et al. 2013), which are usually elevated in response to allergy or parasitic
infection. Suppression of IL-5 leads to decreased presence of eosinophils and
increased parasitic burden (Korenaga et al. 1991). However, limited evidence exists as
to a role of IL-5 directly within the context of Lyme disease. One study demonstrated
that suppression of IL-5, in conjunction with suppression of IL-4, prior to infection led to
significantly decreased spirochete load in various target organs in Lyme disease
susceptible mice (Zeidner et al. 2008). In our study, as no statistically significant
differences were observed in the levels of IL-5 in serum, and as the levels of IL-5 were
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relatively low, it is plausible that IL-5 is only present in the serum due to the inherent
immunological bias of BALB/c mice towards a Th2 immune response and may not serve
an important role in response to B. burgdorferi infection.

By contrast, IL-4 was the most abundant cytokine detected in mouse serum. IL-4 is the
primary effector cytokine produced by Th2 cells (Watanabe et al. 2004). The role of IL4 in Lyme disease progression has been extensively characterized. The notion that
BALB/c mice are a Lyme arthritis-resistant mouse model has been attributed to
development of a Th2 response, with IL-4 being an important cytokine for resistance
(Matyniak and Reiner 1995; Keane-Myers and Nickell 1995). By contrast, subsequent
studies have suggested that IL-4 is not absolutely required for resistance to arthritis
development (Brown and Reiner 1999). The presence of IL-4 in BALB/c mice has been
correlated with a rapid resolution of Lyme arthritis, but does not prevent the
development of arthritis (Kang et al. 1997). Additionally, IL-4 is not believed to be
essential for the control of carditis in the BALB/c mice (Satoskar et al. 2000). These
findings demonstrate conflicting roles of IL-4 in response to infection with B. burgdorferi.
Depletion of Treg cells did not appear to have any significant effect on the levels of IL-4
in serum; however, the presence of IL-4 suggests involvement of other types of immune
cells, which could potentially have been impacted by depletion of Treg cells. IL-4
contributes to the stimulation of antibody production by B cells (Yssl et al. 1991), so the
effect of Treg cell depletion may be visible in B cells and antibody production early in
response to infection with B. burgdorferi.
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IL-4 is present in the serum of BALB/c mice even under normal conditions. This has
been corroborated by the finding that naïve CD4+ T cells produce basal levels of IL-4
under normal conditions, which contributes to the Th2 polarization in BALB/c mice (Yagi
et al. 2006). The presence of IL-4 under steady state conditions could potentially
impact the development of Treg cells. In fact, Th2 and Treg cells appear to be closely
related to one another. Observations in intestinal parasitic infection have suggested
that the timing of exposure to IL-4 could suppress the development of Treg cells by
promoting the loss of Foxp3 and the development of Th2 cells (Pelly et al. 2017). It has
also been reported that, under certain inflammatory conditions, Treg cells lose their
expression of Foxp3, which causes them to become Th2-like cells even under
conditions that would normally promote the development of Th1 cells (Wan et al. 2007).
It could be possible that Treg cells exist in low numbers in BALB/c mice due to the
genetic predisposition towards a Th2-biased immune response, which could explain
why few observable effects of Treg cell depletion on arthritis were observed in the mice
infected with lower doses of B. burgdorferi. Maybe this effect could be overcome by the
use of higher infectious doses in future studies.

Although the cytokine analysis did not support a role for the depletion of Treg cells on
inflammatory mediators, the cytokine profile did provide further support for the Th2 bias
present in BALB/c mice. Taken collectively, the effect of Treg cell depletion on borrelial
load in joint and heart tissue and the lack of an observable effect of Treg cell depletion
on many cytokines present in the serum suggests that Treg cells may actually have an
impact on aspects of the immune response other than on Th1, Th2, or Th17 cells and
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their respective cytokines. Treg cells can exert control over a variety of cell types (ArceSIllas et al. 2016), so future studies could analyze the effect of Treg cell depletion on
other components of the immune response, especially innate cells that are important for
clearance of B. burgdorferi. Some of our data provide support for a role for Treg cells in
the development and progression of Lyme disease; however, additional studies are
needed to further analyze the role of Treg cells in the context of Lyme disease,
particularly within the BALB/c mouse model.
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CHAPTER 5: CONCLUSION AND FUTURE DIRECTIONS

The hypothesis for this thesis was that Treg cells control the development and
progression of Lyme disease following infection with Borrelia burgdorferi. To test this
hypothesis, two specific aims were pursued. The first specific aim focused on the
development of arthritis, with the working hypothesis that Treg cell depletion would
exacerbate both tibiotarsal joint swelling and arthritis. The second specific aim focused
on the ability of Treg cells to control the immune response to B. burgdorferi infection,
with the working hypothesis that Treg cell depletion would lead to increased control of
bacterial dissemination and increased levels of circulating pro-inflammatory cytokines.
The central hypothesis was partially supported by the trends in tibiotarsal joint swelling,
certain aspects of arthritic development, and the borrelial load in joints and heart tissues
observed in mice depleted of Treg cells. Importantly, our results appeared to be
dependent upon the infectious doses of B. burgdorferi that we used.

Multiple directions could be considered when developing future experiments in BALB/c
DEREG mice. Paw swelling trends, particularly those observed in mice infected with
1X103 B. burgdorferi microorganisms, provide support for extending the experimental
duration beyond 35 days. Although no statistically significant differences were observed
between infected DEREG mice previously administered PBS and infected DEREG mice
previously administered DTx, swelling differences between infected DEREG mice
previously administered DTx and infected WT mice previously administered DTx
reached statistical significance by the end the of the experiment. Additionally, tibiotarsal
joint swelling began to decrease in both infected DEREG mice previously administered
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PBS and infected WT mice previously administered DTx, whereas the swelling
observed in infected DEREG mice previously administered DTx began to plateau. The
decrease in swelling suggests a potential resolution of disease when Treg cells were
not depleted. It is possible that depletion of Treg cells affects disease resolution in
BALB/c mice by altering the initial immune response to infection with B. burgdorferi,
which could then stimulate a cascade of downstream immunological effects. Future
experiments could extend the duration of the experiments beyond 35 days.

As infection with 1X102 and 1X103 B. burgdorferi appeared to be too low of infectious
doses to induce arthritis development, it may be beneficial to increase the infectious
dose in future studies. Arthritis severity correlates with increasing infectious doses (Ma
et al. 1998). In addition to increasing the infectious dose for future experiments, it would
be beneficial to determine the effect of Treg cell depletion on carditis, as carditis was
not assessed in these experiments. It has been suggested that the route of inoculation
determines the course of disease progression as spirochetes are more likely to travel to
sites proximal to the site of infection, such as the heart, rather than to distal sites, such
as the joints (Motameni et al. 2005). Additionally, BALB/c mice tend to develop severe
heart disease but only mild joint disease (Moody and Barthold 1998); therefore, the
effects of Treg cell depletion may be more easily observable in carditis, rather than
arthritis.

Lastly, it appeared that the depletion of Treg cells prior to infection affected some
aspects of the immune system that had downstream impacts on the course of disease
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progression. The primary mechanism by which Treg cells control the immune response
is by secretion of anti-inflammatory cytokines, which can act on multiple types of
immune cells in multiple ways (Arce-Sillas et al. 2016). Other components, such as
macrophages, B cells, and antibodies, have been implicated in the response to infection
with B. burgdorferi (Barthold et al. 1991; McKisic and Barthold 2000; Creson et al.
1996), so it may be beneficial to determine the effect of Treg cell depletion on other
aspects of the immune system that may be important for preventing the establishment
of infection. An increase in tibiotarsal joint swelling was observed in DEREG mice
administered DTx prior to infection with 1X102 organisms, demonstrating support for the
role of Treg cells in controlling infection. Although Treg cell depletion is only temporary
in DEREG mice, depletion of Treg cells prior to infection appeared to have been
sufficient to affect the initial immune response to infection. This effect then appeared to
be maintained throughout the experiment, as tibiotarsal joint swelling increased
consistently for the duration of the experiment and, based on the swelling trend, could
have potentially continued beyond the 20 days. In future studies, additional time points
could also be examined earlier during the course of infection, perhaps closer towards
the initial depletion of Treg cells to account for the effect of Treg cell depletion on innate
immune cells and their cytokines.
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